Results 201 to 210 of about 2,690,705 (301)
Iterative hypothesis testing in HIV vaccine research: moving towards success. [PDF]
Anklesaria P, Russell ND.
europepmc +1 more source
Metformin mediates mitochondrial quality control in Leber's hereditary optic neuropathy (LHON) fibroblasts carrying mtDNA mutations. At therapeutic levels, metformin activates AMPK signaling to restore mitochondrial dynamics by promoting fusion and restraining fission, while preserving mitochondrial mass, enhancing autophagy/mitophagy and biogenesis ...
Chatnapa Panusatid +3 more
wiley +1 more source
Statistical Hypothesis Testing with SAS and R
Abdolvahab Khademi
doaj +1 more source
Coconut: covariate-assisted composite null hypothesis testing with applications to replicability analysis of high-throughput experimental data. [PDF]
Li Y, Li Y, Ma H, Yue Z, Zhang X.
europepmc +1 more source
Simultaneous hypothesis testing for multiple competing risks in comparative clinical trials. [PDF]
Wen J, Wang MC, Hu C.
europepmc +1 more source
Surface runoff features on Mars: Testing the carbon dioxide formation hypothesis [PDF]
Sarah T. Stewart, F. Nimmo
openalex +1 more source
Tandem VHH targeting distinct EGFR epitopes were engineered into a monovalent bispecific antibody (7D12‐EGA1‐Fc) with more potent ADCC without increasing affinity to EGFR. Structural modeling of 7D12‐EGA1‐Fc showed cross‐linking of separate EGFR domains to enhance CD16a engagement on NK cells.
Yuqiang Xu +5 more
wiley +1 more source
Evaluating the Accuracy and Explanatory Quality of Large Language Models ChatGPT, Claude, DeepSeek, Gemini, Grok, and Le Chat in Statistical Test Selection for Hypothesis Testing Decisions. [PDF]
Shukla M +5 more
europepmc +1 more source
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava +3 more
wiley +1 more source

